In vivo, GRP tumor growth was faster and maintained the gene signature: ZEB1‐miR200c‐BMI1 axis; high expression of mesenchymal and stem cell‐related factors; and reduced expression of epithelial marker. The gene discussed is BMI1; the disease is neoplasm.